Multidisciplinary options for the correction of chronic nonspecific low back pain syndrome (literature review)

Chronic back pain is the complaint with which patients most often seek medical help from general practitioners, neurologists, surgeons, traumatologists and other subspecialists. Pain in the lower back can be either nonspecific, i. e., have no specific nosologic cause, or be specific, i. e., have a certain pathophysiologic mechanism of occurrence due to both spinal and extra-spinal causes. This fact determines the importance of complex and multidisciplinary assessment of the characteristics of chronic low back pain syndrome.
The aim of the present study was to investigate the possibility of realizing a multidisciplinary approach in the treatment of nonspecific low back pain syndrome.
Results. Low back pain is pain that is localized between the twelfth pair of ribs and the gluteal folds. It is not always possible to determine the source of pain when it is nonspecific; moreover, there is no convincing evidence that clarification of localization will favorably affect the course and outcome of the disease. There are three main causes of nonspecific low back pain: myofascial syndrome; pathology of joints and ligamentous apparatus of the spine; and lumbar osteochondrosis, which is a natural process of degeneration of spinal structures and is observed to varying degrees in all people, increasing significantly with age. It is believed that the pain syndrome of the back region has a multifaceted pathophysiology, which is influenced by somatic pathology, psychological and social factors. This explains the need for an integrated multidisciplinary approach to a particular patient and the compilation of an individual program of treatment, rehabilitation and prevention of subsequent exacerbations. Multidisciplinary approach means complex coordinated parallel work of specialists aimed at solving the problem of chronic pain.
Conclusion. Multidisciplinary approach to the treatment of patients with chronic nonspecific low back pain syndrome is more effective than monotherapy, because it takes into account individual features of clinical symptoms, allows to carry out treatment and rehabilitation according to an individual plan, including a set of interrelated measures aimed at improving the quality of life of the patient and his functional capabilities.

1. Chou R. Low Back Pain. Ann Intern Med. 2021; 174(8):113–128. doi:10.7326/AITC202108170.

2. GBD 2021 Low Back Pain Collaborators. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet. 2023; 5: e316–е329.

3. Foster N. E., Anema J. R., Cherkin D. et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018; 391(10137):2368–2383.

4. Hartvigsen J., Hancock M. J., Kongsted A., Louw Q. et al. What low back pain is and why we need to pay attention. Lancet. 2018; 391(10137):2356–2367. doi:10.1016/s01406736(18)30480x.

5. Lu W., Shen Z., Chen Y. et al. Risk factors analysis and risk prediction model construction of non-specific low back pain: an ambidirectional cohort study. J Orthop Surg Res. 2023; 18(1):545. doi:10.1186/s13018–023–03945–9.

6. Danilov A. B., Danilov A. B. Multidomain approach to the treatment of patients with chronic nonspecific back pain. Journal of Neurology and Psychiatry. S. S. Korsakov. 2020; 120 (7): 113–120. (In Russ.). doi.org/10.17116/jnevro2020120071113

7. Morozov A. M., Sergeev A. N., Kadykov V. A. and others. Assessment of pain in clinical practice. Doctor. 2023; 34 (10): 69–72. (In Russ.). doi: 10.29296/25877305–2023–10–14

8. Golovacheva V. A., Golovacheva A. A. A personalized interdisciplinary approach to the treatment of chronic low back pain: a clinical observation. Medical advice. 2020; (11): 64–69. (In Russ.). doi:10.21518/2079–701X-2020–11–64–69

9. Qaseem A., Wilt T. J., McLean R.M. et al. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017;166(7):514–530. doi:10.7326/M16–2367.

10. Nicol V., Verdaguer C., Daste C. et al. Chronic Low Back Pain: A Narrative Review of Recent International Guidelines for Diagnosis and Conservative Treatment. J Clin Med. 2023; 12(4):1685. doi:10.3390/jcm12041685.

11. Parfenov VA, Yakhno NN, Kukushkin ML, etc. Acute nonspecific (musculoskeletal) lumbar pain. Recommendations of the Russian Society for the Study of Pain (ROIB). Neurology, neuropsychiatry, psychosomatics. 2018; 10 (2): 4–11. (In Russ.). doi: 10.14412/2074–2711–2018–2–4–11

12. Van Wambeke P., Desomer A., Jonckheer P. et al. The belgian national guideline on low back pain and radicular pain: Key roles for rehabilitation, assessment of rehabilitation potential and the prm specialist. Eur. J. Phys. Rehabil. Med. 2020; 56, 220–227.

13. Pangarkar S. S., Kang D. G., Sandbrink, F. et al. Va/dod clinical practice guideline: Diagnosis and treatment of low back pain. J. Gen. Intern. Med. 2019; 34, 2620–2629.

14. Kreiner, D.S., Matz, P., Bono C. M. et al. Guideline summary review: An evidence-based clinical guideline for the diagnosis and treatment of low back pain. Spine J. 2020, 20, 998–1024.

15. Bailly F., Trouvin A. P., Bercier S. et al. Clinical guidelines and care pathway for management of low back pain with or without radicular pain. Joint Bone Spine. 2021; 88(6):105227. doi:10.1016/j.jbspin.2021.105227.

16. Isaykin A. I., Shevtsova G. E., Rozhkov D. O. and others. The role of the muscle factor in the development of lumbar pain. Neurology, neuropsychiatry, psychosomatics. 2017; 9 (2): 95–101. (In Russ.).

17. Wippert P. M., Puschmann A. K., Drießlein D. et al. Development of a risk stratification and prevention index for stratified care in chronic low back pain. Focus: yellow flags (MiSpEx network). PAIN Reports. 2017; 2(6): p e623. doi:10.1097/PR9.0000000000000623.

18. Mitkovsky S. V., Kiparisova E. S., Mitkovsky V. G. Chronic back pain: diagnostic criteria and analysis of coping strategies (review). Saratov scientific and medical journal. 2021; 17 (1): 121–127. (In Russ.).

19. Morozov A. M., Sergeev A. N., Askerov E. M. and others. On the possibility of using the modernized pain scale in clinical practice. Modern problems of science and education. 2020; 5: 81. (In Russ.). doi: 10.17513/spno.30010

20. Elbers S., Wittink H., Konings S. et al. Longitudinal outcome evaluations of Interdisciplinary Multimodal Pain Treatment programmes for patients with chronic primary musculoskeletal pain: A systematic review and meta-analysis. Eur J Pain. 2022; 26(2):310–335. doi:10.1002/ejp.1875.

21. Heigl F., Tobler-Ammann B., Villiger P. M. et al. Relationship between the perceived burden of suffering and the observed quality of ADL task performance before and after a 12-week pain management programme. Scand J Occup Ther. 2022; 29(8):660–669. doi: 10.1080/11038128.2021.1903988.

22. Marin T. J., Van Eerd D., Irvin E. et al. Multidisciplinary biopsychosocial rehabilitation for subacute low back pain. Cochrane Database Syst Rev. 2017; 6(6): CD 002193. doi:10.1002/14651858.CD002193.pub2.

23. Kamper S. J., Apeldoorn A. T., Chiarotto A. et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015; 350: h444. doi:10.1136/bmj.h444.

24. Zagorulko O. I., Medvedeva L. A. Chronic pain: an interdisciplinary approach to treatment and its economic feasibility. Clinical and experimental surgery. Journal named after academician B. V. Petrovsky. 2016. 4: 3 (13): 13–19. (In Russ.).

25. Hayden J. A., Ellis J., Ogilvie R., et al. Exercise therapy for chronic low back pain. Cochrane Database Syst Rev. 2021; 9(9): CD 009790. doi:10.1002/14651858.CD009790.pub2.

26. O'Sullivan P.B., Caneiro J. P., O'Keeffe M. et al. Cognitive Functional Therapy: An Integrated Behavioral Approach for the Targeted Management of Disabling Low Back Pain. Phys Ther. 2018; 98(5):408–423. doi:10.1093/ptj/pzy022.

27. Cherkin D. C., Sherman K. J., Balderson B. H. et al. Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA. 2016; 315(12):1240–1249. doi:10.1001/jama.2016.2323.

28. Rabey M., Slater H., Hebron C. et al. Societal beliefs about pain may be more balanced than previously thought. Results of the Guernsey pain survey. BMC Musculoskelet Disord. 2024; 25(1):72. doi:10.1186/s12891–023–07088–0

29. Parfenov V. A., Yakhno N. N., Davydov O. S. and others. Chronic nonspecific (musculo-skeletal) lumbar pain. Recommendations of the Russian Society for the Study of Pain (ROIB). Neurology, neuropsychiatry, psychosomatics. 2019; 11(2S): 7–16. (In Russ.). doi: 10.14412/2074–2711–2019–2S-7–16

30. Hayden J. A., Ellis J., Ogilvie R. et al. Some types of exercise are more effective than others in people with chronic low back pain: a network meta-analysis. J Physiother. 2021; 67(4):252–262. doi:10.1016/j.jphys.2021.09.004.

31. Owen P. J., Miller C. T., Mundell N. L. et al. Which specific modes of exercise training are most effective for treating low back pain? Network meta-analysis. Br J Sports Med. 2020; 54(21):1279–1287. doi:10.1136/bjsports-2019–100886.

32. Rubinstein S. M., de Zoete A., van Middelkoop M. et al. Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials. BMJ. 2019; 364: l689. doi:10.1136/bmj.l689.

33. Furlan A. D., Giraldo M., Baskwill A. et al. Massage for low-back pain. The Cochrane database of systematic reviews. 2015,9 CD 001929. doi:10.1002/14651858.CD001929.pub3.

34. Brosseau L., Wells G. A., Poitras S. et al. Ottawa Panel evidence-based clinical practice guidelines on therapeutic massage for low back pain. J Bodyw Mov Ther. 2012; 16(4):424–455. doi:10.1016/j.jbmt.2012.04.002.

35. Stochkendahl M. J., Kjaer P., Hartvigsen J. et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2017. doi:10.1007/s00586–017–5099–2.

36. Oliveira C. B., Maher C. G., Pinto R. Z. et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018; 27(11):2791–2803. doi:10.1007/s00586–018–5673–2.

37. Golovacheva V. A., Golovacheva A. A., Fateeva T. G. Psychological methods in the treatment of chronic nonspecific pain in the lower back. Neurology, neuropsychiatry, psychosomatics. 2019; 11 (Suppl. 2): 25–32. (In Russ.). doi:10.14412/2074–2711–2019–2S-25–32

38. Ho E. K., Chen L., Simic M. et al. Psychological interventions for chronic, non-specific low back pain: systematic review with network meta-analysis. BMJ. 2022; 376: e067718. doi:10.1136/bmj-2021–067718.

39. Yang J., Lo W. L.A., Zheng F. et al. Evaluation of Cognitive Behavioral Therapy on Improving Pain, Fear Avoidance, and Self-Efficacy in Patients with Chronic Low Back Pain: A Systematic Review and Meta-Analysis. Pain Res Manag. 2022; 2022:4276175. doi:10.1155/2022/4276175.

40. Zinovieva O. E., Golovacheva A. A. Cognitive functional therapy and nonsteroidal anti-inflammatory drugs in the treatment of low back pain. Medical advice. 2022; (23):78–85. (In Russ.). doi:10.21518/2079–701X-2022–16–23–78–85

41. O'Keeffe M., O'Sullivan P., Purtill H. et al. Cognitive functional therapy compared with a group-based exercise and education intervention for chronic low back pain: a multicentre randomised controlled trial (RCT). Br J Sports Med. 2020; 54(13):782–789. doi:10.1136/bjsports-2019–100780.

42. Diez G. G., Anitua E., Castellanos N. et al. The effect of mindfulness on the inflammatory, psychological and biomechanical domains of adult patients with low back pain: A randomized controlled clinical trial. PLoS One. 2022; 17(11): e0276734. doi:10.1371/journal.pone.027673.

43. Petrucci G., Papalia G. F., Russo F. et al. Psychological Approaches for the Integrative Care of Chronic Low Back Pain: A Systematic Review and Metanalysis. Int J Environ Res Public Health. 2021; 19(1):60. doi:10.3390/ijerph19010060.

44. Migliorini F., Maffulli N. Choosing the appropriate pharmacotherapy for nonspecific chronic low back pain. J Orthop Surg Res. 2022; 17(1):556. doi:10.1186/s13018–022–03426–5.

45. Sorokovikova T. V., Morozov A. M., Kryukova A. N. et al. Modern approach to the diagnosis of migraine. Bulletin of neurology, psychiatry and neurosurgery. 2023; 16 (10): 841–851. (In Russ.). doi:10.33920/med-01–2310–10

46. Bindu S., Mazumder S., Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180:114147. doi:10.1016/j.bcp.2020.114147.

47. Pyrikova N. V., Antropova O. N., Osipova I. V. Adverse reactions from the cardiovascular system when taking non-steroidal anti-inflammatory drugs and ways to reduce them. Rational Pharmacotherapy in Cardiology. 2019; 15 (5): 750–758. (In Russ.). DOI:10.20996/1819–6446–2019–15–5–750–758

48. Nast C. C. Medication-Induced Interstitial Nephritis in the 21st Century. Adv Chronic Kidney Dis. 2017; 24(2):72–79. doi: 10.1053/j.ackd.2016.11.016.

49. Enthoven W. T., Roelofs P. D., Deyo R. A. et al. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. 2016; 2(2): CD 012087. doi:10.1002/14651858.CD012087.

50. Williams C. M., Maher C. G., Latimer J. et al. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014; 384(9954):1586–1596. doi:10.1016/S0140–6736(14)60805–9.

51. Saragiotto B. T., Machado G. C., Ferreira M. L. et al. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016; 2016(6): CD 012230. doi:10.1002/14651858.CD012230.

52. Wewege M. A., Bagg M. K., Jones M. D. et al. Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis. BMJ. 2023; 380: e072962. doi:10.1136/bmj-2022–072962.

53. Nalamachu S., Pergolizzi J., Kaye R. Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565). J Pain Res. 2020; 13:3059–3069doi:10.2147/JPR.S278857.

54. Abdel Shaheed C., Maher C. G., Williams K. A. et al. Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. Eur J Pain. 2017; 21(2):228–237. doi:10.1002/ejp.907.

55. Chiba L., Zhusupova A. S., Likhachev S. A. and others. Systematic review of the use of muscle relaxants for pain in the lower part of the spine Neurologist Zh. Korsakova. 2018; 118 (12): 100–113. (In Russ.). doi: 10.17116/jnevro2018118121100

56. Churyukanov M. V. Cyclobenzaprine in the treatment of musculoskeletal pain. Russian Journal of Pain. 2022; 20 (1): 71–76. (In Russ.). doi:10.17116/pain20222001171

57. Ma T., Qi H., Mao Y. et al. Comparative Efficacy and Safety of Antidepressants for Patients with Chronic Back Pain: A Network Meta-Analysis. J Clin Pharmacol. 2024;64(2):205–214. doi:10.1002/jcph.2365.

58. Skljarevski V., Desaiah D., Liu-Seifert H. et al. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine (Phila Pa 1976). 2010; 35(13): E 578-E 585. doi:10.1097/BRS.0b013e3181d3cef6.

59. Weng C., Xu J., Wang Q. et al. Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain: a Systematic review and meta-analysis. Osteoarthritis Cartilage. 2020; 28(6):721–734. doi:10.1016/j.joca.2020.03.001.

60. National Guideline Centre (UK). Low Back Pain and Sciatica in Over 16s: Assessment and Management. London: National Institute for Health and Care Excellence (NICE); November 2016.

61. Torshin I. Yu., Gromova O. A. About the neurological functions and synergism of vitamins B 1, B 6, B 12. Russian Journal of Pain. 2022; 20 (1):56–64. (In Russ.). doi:10.17116/pain20222001156